Longevity Drugs Need Endpoints That Predict Clinical Benefit
Candidate measures that could be linked to the biology of aging were discussed at a May 2026 public meeting convened by the Reagan-Udall Foundation for the FDA with the Advanced Research Projects Agency for Health.